From early to late phase, our oncology expertise supports you—integrating Project Optimus & FrontRunner, accelerating enrollment, easing site burden, and keeping trials on track. Discover our approach: bit.ly/46Ch6gd

Finding a #CRO that meets all your clinical needs is hard, but not impossible. With IQVIA Biotech’s multidisciplinary Cell and Gene Therapy Study Management team, you can achieve your research goals with confidence. Learn how. bit.ly/40cCODF

Join IQVIA’s on-demand webinar to explore strategies for clinical trial success. Put #patientsfirst to enhance representation and drive engagement. Watch now. bit.ly/44pXj2b

What if your trials were designed with patients, not just for them? By looking beyond data and truly understanding their journey, we can create more patient-centered processes, improve outcomes and enhance their satisfaction. Read the full insight. bit.ly/4lwm5nq

Cracking the code on high placebo rates in #dermatologytrials is key to revealing true treatment results. From smarter #patientselection to top-notch site training, delve into expert strategies to help boost trial success. Read our blog. bit.ly/3GGkJaz

Rare diseases present complex challenges. Choosing your clinical development partner shouldn't. Deliver complex trials on time and chart a smarter path to market with IQVIA Biotech. bit.ly/4kKrBlh

How is the #oncology community staying ahead of cancer? Explore key takeaways from #ASCO25 and learn how they can impact #biotech sponsors around the world. Read article: bit.ly/4kErIyw

As Therapeutic Strategy Director for IQVIA Biotech, Sarah Kromrey, PhD, specializes in #rarediseases. Focusing on disease impact and patient needs, Sarah knows how to navigate the complex regulatory landscape of novel treatments. Read more. bit.ly/4eOWAuY

Our #CVRM team has operational experience and expertise across a broad spectrum of chronic and acute indications. From acute coronary syndrome, heart failure, kidney disease and diabetes, to hyperlipidemia, and more. Visit our website to learn more. bit.ly/4mkCR9h

How to approach long-term follow-up (#LTFU) studies? Download the IQVIA Biotech Insight Brief to learn how to tackle challenges in CAGT and ensure patient-centered outcomes. bit.ly/40qYqfP

IQVIA Biotech offers comprehensive resources across all therapeutic areas – including #rarediseases and the full spectrum of cell and gene therapies – without unnecessary complexities. Explore our full-service clinical development. bit.ly/44SwWkp

Long-term follow-up for patients who have received a #genetherapy can present unique challenges for #biotech companies. Discover solutions to overcome these challenges in this insight brief: bit.ly/4m3ZU7Z

What are the top 5 challenges in Immuno-oncology (#IO) clinical trials? Learn how our biotech-centered approach can help you successfully navigate IO trials. bit.ly/4m4PHbl

The success of your clinical development program hinges on having a team with relevant expertise that understands your every need. That’s why IQVIA Biotech hand-selects the team that’s right for you. Find out more. bit.ly/3UmPCE6

Ready to take your oncology trial to the next level? With our unparalleled #oncology expertise, IQVIA Biotech has supported 500+ oncology #clinicaltrials in the past 5 years. Speak to our dedicated oncology team today: bit.ly/4kTwuZd

Patient's voice matter. We need to listen. Their perspectives can lead to higher enrollment and more reliable outcomes, driving meaningful change to the entire process. Read our insight brief. bit.ly/417lVKU

Meet study milestones. Expand clinical development. Maximize #patientimpact. Discover why our dedicated #CVRM team at IQVIA Biotech is the partner you can rely on. bit.ly/3H1oYxu

Many #CNS disorders lack effective therapies. Connect with an experienced partner with scientific experts, data and global resources so you can focus on what matters most: getting breakthrough treatments to patients. bit.ly/3H6CorY

The impact of #CAGT is on the rise. Stay ahead of the curve and learn how you can address #clinicaldevelopment challenges in our latest insight brief. bit.ly/4kVEskE

Cardiovascular, Renal and Metabolic (#CVRM) health represents the fastest expanding disease spectrum globally. It's time to take proper action. Learn how IQVIA Biotech’s #CVRM experience can help you deliver the best outcomes. bit.ly/4fbjlJS